Grant winners

September 6, 2012

BIOTECHNOLOGY AND BIOLOGICAL SCIENCES RESEARCH COUNCIL

Responsive Mode Grants

Values are the amounts requested. Awarded amounts may differ.

• Award winner: Alasdair Nisbet

• Institution: Moredun Research Institute

• Value: £410,000

Development of a vaccine to control poultry red mite

• Award winner: John Brown

• Institution: University of Dundee

• Value: £17,000

Regulation of (1,3;1,4)-beta-glucan synthesis in the grasses

ADVERTISEMENT

• Award winner: John West

• Institution: University of Edinburgh

• Value: £252,000

An integrated experimental and theoretical approach to understanding corneal epithelial maintenance

• Award winner: Andrew Lovering

• Institution: University of Birmingham

• Value: £619,000

Understanding the role of peptidoglycan metabolism in bacterial predation

ADVERTISEMENT

• Award winner: Peter Nixon

• Institution: Imperial College London

• Value: £60,000

Spatial dynamics of electron transport

NATIONAL CENTRE FOR THE REPLACEMENT, REFINEMENT AND REDUCTION OF ANIMALS IN RESEARCH - NC3RS

Project Grants

• Award winner: Chris Denning

• Institution: University of Nottingham

• Value: £412,735

Human pluripotent stem cell cardiomyocytes and hepatocytes with engineered genotypes for drug safety evaluation

• Award winner: Michael Mendl

• Institution: University of Bristol

• Value: £332,388

Development and validation of an automated test of animal affect and welfare for laboratory rodents

Pilot Study Grants

• Award winner: Donna MacCallum

• Institution: University of Aberdeen

• Value: £74,997

Live real-time imaging of life-threatening invasive fungal infections

ADVERTISEMENT

ECONOMIC AND SOCIAL RESEARCH COUNCIL

Successful Rising Powers and Interdependent Futures Research Grants

• Award winner: Marcus Power

• Institution: Durham University

• Value: £602,709

The rising powers, clean development and the low carbon transition in sub-Saharan Africa

• Award winner: Khalid Nadvi

• Institution: University of Manchester

• Value: £637,907

Rising powers, labour standards and the governance of global production networks

IN DETAIL

National Institute for Health Research

• Award winner: Gus Gazzard

• Institution: Moorfields Eye Hospital NHS Foundation Trust

ADVERTISEMENT

• Value: £1,692,821

Health-related quality of life in two treatment pathways for primary open angle glaucoma and ocular hypertension: a randomised controlled trial of initial selective laser trabeculoplasty versus conventional medical therapy

Glaucoma is a major problem in the UK. This study responds to National Institute for Health and Clinical Excellence guidance on the treatment of the disease and the Cochrane Systematic Review's recommendations for research into laser trabeculoplasty. It proposes to compare the quality of life of patients who start treatment with medicines (eye drops) to those who are first treated with laser trabeculoplasty (laser treatment to the "angle" inside the front of the eye) and then receive drops later as necessary.

ADVERTISEMENT

Register to continue

Why register?

  • Registration is free and only takes a moment
  • Once registered, you can read 3 articles a month
  • Sign up for our newsletter
Register
Please Login or Register to read this article.

Sponsored

ADVERTISEMENT